Michael “Mike” Froy joined the Lymphoma Research Foundation’s Board of Directors in 2019. He is a partner in the corporate group of Dentons (the world’s largest law firm), where he has practiced his entire career, advising clients on meeting their business objectives and serving in many global and national leadership positions. He has been a director of both for profit and nonprofit organizations, currently serving on four nonprofit boards in addition to LRF.
In 2017, Mike was diagnosed with extranodal NK/T cell lymphoma, an extremely rare form of non-Hodgkin lymphoma. The day Mike was diagnosed he was connected with LRF which provided Mike with critical background information and physician referrals. Following successful treatment, Mike is a Lymphoma Thriver having benefitted from scientific research that resulted in new therapies with substantially improved outcomes.